tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SEPN Stock Latest News

Septerna Reports Q2 2025 Financial Results and Progress
Company AnnouncementsSepterna Reports Q2 2025 Financial Results and Progress
3d ago
SEPN
Septerna Appoints Liz Bhatt as New President
PremiumCompany Announcements
Septerna Appoints Liz Bhatt as New President
12d ago
8K
SEPN
Septerna Announces Collaboration with Novo Nordisk
PremiumCompany Announcements
Septerna Announces Collaboration with Novo Nordisk
1M ago
8K
SEPN
Septerna initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Septerna initiated with a Buy at H.C. Wainwright
2M ago
SEPN
Septerna, Inc. Holds Virtual Annual Stockholders Meeting
PremiumCompany Announcements
Septerna, Inc. Holds Virtual Annual Stockholders Meeting
2M ago
8K
SEPN
Sector Spotlight: Trump executive order targets drug prices
PremiumThe FlySector Spotlight: Trump executive order targets drug prices
3M ago
CI
BMY
Septerna price target raised to $18 from $11 at Wells Fargo
Premium
The Fly
Septerna price target raised to $18 from $11 at Wells Fargo
3M ago
NVO
SEPN
Septerna, Inc.: Strategic Partnerships and Promising Pipeline Drive Buy Rating
Premium
Ratings
Septerna, Inc.: Strategic Partnerships and Promising Pipeline Drive Buy Rating
3M ago
SEPN
Septerna reports Q1 EPS (49c), consensus (45c)
PremiumThe Fly
Septerna reports Q1 EPS (49c), consensus (45c)
3M ago
SEPN
Novo Nordisk (NVO) Signs $2.2B Deal to Develop Weight-Loss Pills
PremiumMarket News
Novo Nordisk (NVO) Signs $2.2B Deal to Develop Weight-Loss Pills
3M ago
NVO
SEPN
Septerna Enters Major Collaboration with Novo Nordisk
PremiumCompany Announcements
Septerna Enters Major Collaboration with Novo Nordisk
3M ago
8K
SEPN
Novo Nordisk, Septerna to collaborate to develop obesity pills
PremiumThe Fly
Novo Nordisk, Septerna to collaborate to develop obesity pills
3M ago
NVO
SEPN
Septerna, Inc. Reports 2024 Financial Results and Strategic Progress
PremiumCompany AnnouncementsSepterna, Inc. Reports 2024 Financial Results and Strategic Progress
5M ago
SEPN
Septerna price target lowered to $11 from $14 at Wells Fargo
Premium
The Fly
Septerna price target lowered to $11 from $14 at Wells Fargo
5M ago
SEPN
Septerna reports Q4 EPS (64c), consensus (69c)
Premium
The Fly
Septerna reports Q4 EPS (64c), consensus (69c)
5M ago
SEPN
Septerna sees cash runway into early 2028
PremiumThe Fly
Septerna sees cash runway into early 2028
5M ago
SEPN
Septerna, Inc. Shifts Focus to Next-Gen PTH1R Agonist
PremiumCompany Announcements
Septerna, Inc. Shifts Focus to Next-Gen PTH1R Agonist
6M ago
8K
SEPN
Hold Rating for Septerna, Inc. Amid Lead Program Discontinuation and Pipeline Uncertainty
PremiumRatings
Hold Rating for Septerna, Inc. Amid Lead Program Discontinuation and Pipeline Uncertainty
6M ago
SEPN
Wells Fargo downgrades Septerna after lead program SEP-786 discontinued
PremiumThe Fly
Wells Fargo downgrades Septerna after lead program SEP-786 discontinued
6M ago
SEPN
Septerna downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe FlySepterna downgraded to Equal Weight from Overweight at Wells Fargo
6M ago
SEPN
Septerna discontinues SEP-786 Phase 1 clinical trial in hypoparathyroidism
Premium
The Fly
Septerna discontinues SEP-786 Phase 1 clinical trial in hypoparathyroidism
6M ago
SEPN
Nine new option listings on February 12th
Premium
The Fly
Nine new option listings on February 12th
6M ago
NA
CTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >